Mark E. Borowsky

1.7k total citations
24 papers, 896 citations indexed

About

Mark E. Borowsky is a scholar working on Reproductive Medicine, Oncology and Epidemiology. According to data from OpenAlex, Mark E. Borowsky has authored 24 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 8 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Mark E. Borowsky's work include Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and Endometriosis Research and Treatment (4 papers). Mark E. Borowsky is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and Endometriosis Research and Treatment (4 papers). Mark E. Borowsky collaborates with scholars based in United States, Argentina and Canada. Mark E. Borowsky's co-authors include Rugang Zhang, C. Bethan Powell, Jeanne Carter, Lynn P. Parker, Randall K. Gibb, Mark G. Cadungog, Joan L. Walker, Nail Fatkhutdinov, Takeshi Fukumoto and Michael J. Allegrezza and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Mark E. Borowsky

24 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Borowsky United States 13 339 329 250 237 165 24 896
Andrew N. Stephens Australia 17 304 0.9× 342 1.0× 339 1.4× 221 0.9× 104 0.6× 32 892
Yasuhisa Terao Japan 15 408 1.2× 317 1.0× 221 0.9× 67 0.3× 226 1.4× 74 953
Ritsuto Fujiwaki Japan 17 357 1.1× 215 0.7× 196 0.8× 90 0.4× 206 1.2× 55 834
Alla Lisyanskaya Russia 15 233 0.7× 447 1.4× 550 2.2× 109 0.5× 139 0.8× 49 1.1k
Koji Yamanoi Japan 12 290 0.9× 464 1.4× 164 0.7× 362 1.5× 93 0.6× 72 946
Nana Tchabo United States 14 326 1.0× 235 0.7× 204 0.8× 107 0.5× 133 0.8× 25 744
Marcella Falchetti Italy 16 225 0.7× 274 0.8× 234 0.9× 97 0.4× 231 1.4× 19 803
Sandrina Lambrechts Belgium 18 280 0.8× 236 0.7× 402 1.6× 74 0.3× 184 1.1× 36 777
Eleftherios Pierre Samartzis Switzerland 24 500 1.5× 338 1.0× 697 2.8× 241 1.0× 375 2.3× 43 1.3k
Andrew Shih United States 15 211 0.6× 174 0.5× 151 0.6× 344 1.5× 116 0.7× 34 694

Countries citing papers authored by Mark E. Borowsky

Since Specialization
Citations

This map shows the geographic impact of Mark E. Borowsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Borowsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Borowsky more than expected).

Fields of papers citing papers by Mark E. Borowsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Borowsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Borowsky. The network helps show where Mark E. Borowsky may publish in the future.

Co-authorship network of co-authors of Mark E. Borowsky

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Borowsky. A scholar is included among the top collaborators of Mark E. Borowsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Borowsky. Mark E. Borowsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, P. H., et al.. (2024). Evaluation of Sentinel Lymph Nodes in Complex Atypical Endometrial Hyperplasia. 2(2). 97–107. 3 indexed citations
3.
Borowsky, Mark E., et al.. (2023). Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer. Southern Medical Journal. 116(10). 790–794. 1 indexed citations
4.
Borowsky, Mark E., et al.. (2021). Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer. Southern Medical Journal. 114(11). 680–685. 2 indexed citations
5.
Karakashev, Sergey, Takeshi Fukumoto, Bo Zhao, et al.. (2020). EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition. Cancer Cell. 37(2). 157–167.e6. 97 indexed citations
6.
Nacarelli, Timothy, Takeshi Fukumoto, Joseph A. Zundell, et al.. (2019). NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer. Cancer Research. 80(4). 890–900. 112 indexed citations
7.
Zhao, Bo, Jianhuang Lin, Lijie Rong, et al.. (2019). ARID1A promotes genomic stability through protecting telomere cohesion. Nature Communications. 10(1). 4067–4067. 40 indexed citations
8.
Borowsky, Mark E., et al.. (2019). The rate of incidental uterine malignant and premalignant lesions at supracervical hysterectomy for uterovaginal prolapse. Gynecologic Oncology. 154(1). e11–e11. 1 indexed citations
9.
Harper, Sandra L., Aaron R. Goldman, Benjamin G. Bitler, et al.. (2018). CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer. Scientific Reports. 8(1). 14725–14725. 33 indexed citations
10.
Stephen, Tom L., Kyle K. Payne, Ricardo A. Chaurio, et al.. (2017). SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells. Immunity. 46(1). 51–64. 115 indexed citations
11.
Tesone, Amelia J., Melanie R. Rutkowski, Eva Brencicova, et al.. (2016). Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells. Cell Reports. 14(7). 1774–1786. 86 indexed citations
12.
Walker, Joan L., C. Bethan Powell, Lee-may Chen, et al.. (2015). Society of Gynecologic Oncology Recommendations for the Prevention of Ovarian Cancer. Obstetrical & Gynecological Survey. 70(7). 448–449. 31 indexed citations
13.
Borowsky, Mark E., et al.. (2015). Case report: Atypical, ‘symplastic’ leiomyoma recurring as leiomyosarcoma in the vagina. SHILAP Revista de lepidopterología. 14. 4–5. 3 indexed citations
14.
Wasson, Megan, et al.. (2015). Morcellation and the Incidence of Occult Uterine Malignancy. International Journal of Gynecological Cancer. 26(1). 149–155. 35 indexed citations
15.
Stephen, Tom L., Melanie R. Rutkowski, Michael J. Allegrezza, et al.. (2014). Transforming Growth Factor β-Mediated Suppression of Antitumor T Cells Requires FoxP1 Transcription Factor Expression. Immunity. 41(3). 427–439. 92 indexed citations
16.
Borowsky, Mark E., et al.. (2013). Intraperitoneal Chemotherapy in a Pregnant Woman With Ovarian Cancer. Obstetrics and Gynecology. 122(2). 481–483. 14 indexed citations
17.
Borowsky, Mark E., et al.. (2011). Port-site metastasis following robotic-assisted radical hysterectomy for squamous cell cervical cancer. PubMed. 2(2). 32–34. 9 indexed citations
18.
Borowsky, Mark E., et al.. (2005). Malignant thymoma metastatic to the pelvis: A rare case and considerations for management. Gynecologic Oncology. 99(1). 228–231. 2 indexed citations
19.
Borowsky, Mark E., et al.. (2004). Prolonged survival in recurrent endometrial carcinoma to the brain. Gynecologic Oncology. 95(1). 247–251. 13 indexed citations
20.
Francis, Michelle, et al.. (2003). Pericardial effusion, right-sided pleural effusion and ascites associated with stage IV endometriosis. A case report.. PubMed. 48(6). 463–5. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026